Susan G. Komen
@susangkomen.bsky.social
Breast cancer research
Breast cancer care & financial support
Breast health advocacy & public policy
Breast cancer care & financial support
Breast health advocacy & public policy
Through ShareForCures, we’ll connect different types of health data from thousands of people over time to create one of the most valuable tools available for breast cancer research.
You can help discover cures for breast cancer, faster. Learn more: https://www.komen.org/shareforcures/
You can help discover cures for breast cancer, faster. Learn more: https://www.komen.org/shareforcures/
January 16, 2026 at 12:58 AM
Through ShareForCures, we’ll connect different types of health data from thousands of people over time to create one of the most valuable tools available for breast cancer research.
You can help discover cures for breast cancer, faster. Learn more: https://www.komen.org/shareforcures/
You can help discover cures for breast cancer, faster. Learn more: https://www.komen.org/shareforcures/
Komen’s Center for Public Policy announced its 2026 federal and state advocacy priorities, underscoring the need to protect affordability of and access to high-quality health care for the breast cancer community.
Learn more: https://bit.ly/45HZmyN
Learn more: https://bit.ly/45HZmyN
January 13, 2026 at 7:30 PM
Komen’s Center for Public Policy announced its 2026 federal and state advocacy priorities, underscoring the need to protect affordability of and access to high-quality health care for the breast cancer community.
Learn more: https://bit.ly/45HZmyN
Learn more: https://bit.ly/45HZmyN
It’s important to remember that just because you have a risk factor doesn’t mean that you will get breast cancer. Talk with your doctor about your risk of breast cancer and together develop a breast cancer screening plan that’s right for you.
Learn more at komen.org
Learn more at komen.org
January 10, 2026 at 7:04 PM
It’s important to remember that just because you have a risk factor doesn’t mean that you will get breast cancer. Talk with your doctor about your risk of breast cancer and together develop a breast cancer screening plan that’s right for you.
Learn more at komen.org
Learn more at komen.org
“Am I eligible for a clinical trial?”
Clinical trials aren’t a last resort. They help create better options & exist at every stage.
📖 Read more from our latest Know More blog: https://bit.ly/3LDaXZd
Clinical trials aren’t a last resort. They help create better options & exist at every stage.
📖 Read more from our latest Know More blog: https://bit.ly/3LDaXZd
January 9, 2026 at 3:36 PM
“Am I eligible for a clinical trial?”
Clinical trials aren’t a last resort. They help create better options & exist at every stage.
📖 Read more from our latest Know More blog: https://bit.ly/3LDaXZd
Clinical trials aren’t a last resort. They help create better options & exist at every stage.
📖 Read more from our latest Know More blog: https://bit.ly/3LDaXZd
Join us in the fight against breast cancer and you could score big! Like Super Bowl BIG.
Enter now for your chance to win 2 tickets to Super Bowl LX on Feb. 8, 2026 at Levi’s Stadium in Santa Clara, CA!
For details & more info about how to enter visit: Komen.org/BigGame2026
Enter now for your chance to win 2 tickets to Super Bowl LX on Feb. 8, 2026 at Levi’s Stadium in Santa Clara, CA!
For details & more info about how to enter visit: Komen.org/BigGame2026
January 6, 2026 at 6:09 PM
Join us in the fight against breast cancer and you could score big! Like Super Bowl BIG.
Enter now for your chance to win 2 tickets to Super Bowl LX on Feb. 8, 2026 at Levi’s Stadium in Santa Clara, CA!
For details & more info about how to enter visit: Komen.org/BigGame2026
Enter now for your chance to win 2 tickets to Super Bowl LX on Feb. 8, 2026 at Levi’s Stadium in Santa Clara, CA!
For details & more info about how to enter visit: Komen.org/BigGame2026
There is no way around it, breast cancer is hard. But as today's guest on Real Pink will tell you, trying to remain upbeat throughout treatment can have a positive impact on your life.
Listen today: http://bit.ly/3IderPW
Listen today: http://bit.ly/3IderPW
January 5, 2026 at 9:27 PM
There is no way around it, breast cancer is hard. But as today's guest on Real Pink will tell you, trying to remain upbeat throughout treatment can have a positive impact on your life.
Listen today: http://bit.ly/3IderPW
Listen today: http://bit.ly/3IderPW
Yes, it's true! Breast cancer can also affect men.
Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: https://bit.ly/43p0HJA
Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: https://bit.ly/43p0HJA
January 5, 2026 at 5:54 PM
Yes, it's true! Breast cancer can also affect men.
Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: https://bit.ly/43p0HJA
Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: https://bit.ly/43p0HJA
The early bird catches the discount!
Register today for 50% off your 2026 registration with code EARLYBIRD at www.the3day.org/register. Hurry before this promotion flies away!
Register today for 50% off your 2026 registration with code EARLYBIRD at www.the3day.org/register. Hurry before this promotion flies away!
January 3, 2026 at 3:27 PM
The early bird catches the discount!
Register today for 50% off your 2026 registration with code EARLYBIRD at www.the3day.org/register. Hurry before this promotion flies away!
Register today for 50% off your 2026 registration with code EARLYBIRD at www.the3day.org/register. Hurry before this promotion flies away!
Let's make 2026 the year of healthy living! Taking care of yourself and having a sense of happiness and well-being is an important part of your health.
What new things do you want to try this year?
What new things do you want to try this year?
January 2, 2026 at 8:57 PM
Let's make 2026 the year of healthy living! Taking care of yourself and having a sense of happiness and well-being is an important part of your health.
What new things do you want to try this year?
What new things do you want to try this year?
Our “EmpowerED: Education After Diagnosis” event took place on Dec. 8, bringing together attendees for an evening of education, support and meaningful conversations, including a discussion about the power of asking for help and supporting one another.
https://bit.ly/48KDOUk
https://bit.ly/48KDOUk
December 23, 2025 at 5:54 PM
Our “EmpowerED: Education After Diagnosis” event took place on Dec. 8, bringing together attendees for an evening of education, support and meaningful conversations, including a discussion about the power of asking for help and supporting one another.
https://bit.ly/48KDOUk
https://bit.ly/48KDOUk
Update! FDA approves T-DXd (trastuzumab deruxtecan) combined with petuzumab for HER2+ metastatic breast cancer as 1st line treatment - backed by DESTINY-Breast09 clinical trial results.
Learn more here: https://bit.ly/4pIyc2V
Learn more here: https://bit.ly/4pIyc2V
December 18, 2025 at 3:51 PM
Update! FDA approves T-DXd (trastuzumab deruxtecan) combined with petuzumab for HER2+ metastatic breast cancer as 1st line treatment - backed by DESTINY-Breast09 clinical trial results.
Learn more here: https://bit.ly/4pIyc2V
Learn more here: https://bit.ly/4pIyc2V
"It's so important to always have advocates involved because it allows us to ask those questions to researchers like 'how will this help?'" - Komen patient advocate Bob Ritter shares his thoughts on all the research updates coming from @sabcs.bsky.social #SABCS
December 12, 2025 at 10:10 PM
"It's so important to always have advocates involved because it allows us to ask those questions to researchers like 'how will this help?'" - Komen patient advocate Bob Ritter shares his thoughts on all the research updates coming from @sabcs.bsky.social #SABCS
This week at #SABCS25, we presented pivotal work aimed at addressing needs within the #breastcancer community. Read more about the Komen-led research projects: https://bit.ly/4pyiJCe @sabcs.bsky.social
December 12, 2025 at 8:37 PM
This week at #SABCS25, we presented pivotal work aimed at addressing needs within the #breastcancer community. Read more about the Komen-led research projects: https://bit.ly/4pyiJCe @sabcs.bsky.social
🔬 We’re watching the science at #SABCS25. Komen Scholar Susan Domchek, M.D., is excited about the WISDOM trial using genetics & polygenic risk scores to personalize screening. @sabcs.bsky.social
📖 Read more: https://www.komen.org/blog/sabcs-watch-2025/
📖 Read more: https://www.komen.org/blog/sabcs-watch-2025/
December 12, 2025 at 4:27 PM
🔬 We’re watching the science at #SABCS25. Komen Scholar Susan Domchek, M.D., is excited about the WISDOM trial using genetics & polygenic risk scores to personalize screening. @sabcs.bsky.social
📖 Read more: https://www.komen.org/blog/sabcs-watch-2025/
📖 Read more: https://www.komen.org/blog/sabcs-watch-2025/
🚀 At #SABCS25, Ben Park, MD, PhD showed how cell signals go "off the rails" in breast cancer and how his groundbreaking work with cfDNA is changing care by helping earlier detection, better treatment tracking, and spotting metastasis sooner. @sabcs.bsky.social
December 12, 2025 at 3:27 PM
🚀 At #SABCS25, Ben Park, MD, PhD showed how cell signals go "off the rails" in breast cancer and how his groundbreaking work with cfDNA is changing care by helping earlier detection, better treatment tracking, and spotting metastasis sooner. @sabcs.bsky.social
🎉 Congrats to Komen grantees Armando Giuliano MD and Nolan Priedigkeit MD for receiving awards at this year’s @sabcs.bsky.social! #SABCS25 👏👏
December 11, 2025 at 7:07 PM
🎉 Congrats to Komen grantees Armando Giuliano MD and Nolan Priedigkeit MD for receiving awards at this year’s @sabcs.bsky.social! #SABCS25 👏👏
📢 We’re at #SABCS25! Stop by our booth in the Patient Advocacy Pavilion in the @sabcs.bsky.social Exhibition Hall! We’d love to talk to you about Komen’s mission including patient navigation, policy, research-support, education, and more!
December 11, 2025 at 6:45 PM
📢 We’re at #SABCS25! Stop by our booth in the Patient Advocacy Pavilion in the @sabcs.bsky.social Exhibition Hall! We’d love to talk to you about Komen’s mission including patient navigation, policy, research-support, education, and more!
Komen Scholar and Advocates in Science Steering Committee member Barbara Segarra-Vazquez highlights how advocates can drive meaningful change across research in the Partnership for Change session at #SABCS25. @sabcs.bsky.social
December 11, 2025 at 6:38 PM
Komen Scholar and Advocates in Science Steering Committee member Barbara Segarra-Vazquez highlights how advocates can drive meaningful change across research in the Partnership for Change session at #SABCS25. @sabcs.bsky.social
Komen grantee David Cescon discusses exciting advances in liquid biopsy tests for early breast cancer presented at #SABCS25. @sabcs.bsky.social
December 11, 2025 at 6:36 PM
Komen grantee David Cescon discusses exciting advances in liquid biopsy tests for early breast cancer presented at #SABCS25. @sabcs.bsky.social
Komen Scholar Reshma Jagsi M.D., D. Phil. highlighted research at #SABCS25 that could reduce the burden of treatment, like fewer lymph node surgeries & radiation that boosts the immune system.
📖 See what’s ahead and what we’re excited to learn about @sabcs.bsky.social here: https://bit.ly/4pWBEqa
📖 See what’s ahead and what we’re excited to learn about @sabcs.bsky.social here: https://bit.ly/4pWBEqa
December 11, 2025 at 2:47 PM
Komen Scholar Reshma Jagsi M.D., D. Phil. highlighted research at #SABCS25 that could reduce the burden of treatment, like fewer lymph node surgeries & radiation that boosts the immune system.
📖 See what’s ahead and what we’re excited to learn about @sabcs.bsky.social here: https://bit.ly/4pWBEqa
📖 See what’s ahead and what we’re excited to learn about @sabcs.bsky.social here: https://bit.ly/4pWBEqa
👏Komen honored our new early-career grantees during a celebration at #SABCS25. We are so proud to support the next generation of breast cancer leaders, investing in a talented workforce for years to come! 🎉
Learn more: https://bit.ly/49prhq1 @sabcs.bsky.social
Learn more: https://bit.ly/49prhq1 @sabcs.bsky.social
December 11, 2025 at 1:40 AM
👏Komen honored our new early-career grantees during a celebration at #SABCS25. We are so proud to support the next generation of breast cancer leaders, investing in a talented workforce for years to come! 🎉
Learn more: https://bit.ly/49prhq1 @sabcs.bsky.social
Learn more: https://bit.ly/49prhq1 @sabcs.bsky.social
Komen Scholar, Dr. Sunil Badve, presented how immune cells in residual tumors vary by breast cancer subtype in the ECOG-ACRIN EA1131 trial at #SABCS25. @sabcs.bsky.social
December 11, 2025 at 1:38 AM
Komen Scholar, Dr. Sunil Badve, presented how immune cells in residual tumors vary by breast cancer subtype in the ECOG-ACRIN EA1131 trial at #SABCS25. @sabcs.bsky.social
Another DESTINY-Breast09 update from Mothaffar Rimawi MD at #SABCS25: in HER2+ advanced breast cancer, first-line T-DXd + pertuzumab kept pain and daily functioning similar to standard THP, with more stomach issues but fewer skin and swelling symptoms 🩺📈 @sabcs.bsky.social
December 10, 2025 at 8:08 PM
Another DESTINY-Breast09 update from Mothaffar Rimawi MD at #SABCS25: in HER2+ advanced breast cancer, first-line T-DXd + pertuzumab kept pain and daily functioning similar to standard THP, with more stomach issues but fewer skin and swelling symptoms 🩺📈 @sabcs.bsky.social
🩺🧬 Shanu Modi, MD shared DESTINY-Breast11 patient-reported outcomes: In high-risk HER2+ early breast cancer, T-DXd–based pre-surgery therapy helped more patients keep up physical functioning & daily activities vs ddAC-THP, with overall manageable side effects #SABCS25
December 10, 2025 at 8:08 PM
🩺🧬 Shanu Modi, MD shared DESTINY-Breast11 patient-reported outcomes: In high-risk HER2+ early breast cancer, T-DXd–based pre-surgery therapy helped more patients keep up physical functioning & daily activities vs ddAC-THP, with overall manageable side effects #SABCS25
At #SABCS25, Kevin Punie MD presented on ASCENT-03 patient-reported outcomes: In untreated advanced TNBC not eligible for immunotherapy, sacituzumab govitecan helped patients maintain physical activity and overall well-being better than chemo @sabcs.bsky.social
December 10, 2025 at 8:07 PM
At #SABCS25, Kevin Punie MD presented on ASCENT-03 patient-reported outcomes: In untreated advanced TNBC not eligible for immunotherapy, sacituzumab govitecan helped patients maintain physical activity and overall well-being better than chemo @sabcs.bsky.social